PARP9 Antikörper (AA 117-824)
Kurzübersicht für PARP9 Antikörper (AA 117-824) (ABIN7870251)
Target
Alle PARP9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 117-824
-
Verwendungszweck
- PARP9 Antibody
-
Aufreinigung
- Affinity purified
-
Immunogen
- A human recombinant partial protein (amino acids R117-E824) was used as the immunogen for the PARP9 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the PARP9 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the PARP9 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- PARP9 (Poly (ADP-Ribose) Polymerase Family, Member 9 (PARP9))
-
Andere Bezeichnung
- PARP9
-
Hintergrund
- Poly (ADP-ribosyl)ation is a post-translational modification of proteins mediated by one of the 17 members of the poly(ADP-ribose) polymerases (PARP). PARP-9 belongs to the subfamily of macroPARPs, associating one to three macro domains to the PARP domain. Overexpression of PARP-9 stimulates cell migration in vitro, suggesting a role for PARP-9 in the promotion of malignant B cell migration and dissemination in high risk DLBCL. PARP-9 is also likely a transcription coactivator, its overexpression in B lymphocytes, stimulated by IFN?, inducing the transcription of IFN?-controlled genes.
-
UniProt
- Q8IXQ6
Target
-